Supercritical CO extraction is a green method that combines economic and environmental benefits. Microalgae, on the other hand, is a biomass in abundance, capable of providing a vast variety of valuable compounds, finding applications in the food industry, cosmetics, pharmaceuticals and biofuels. An extensive study on the existing literature concerning supercritical fluid extraction (SFE) of microalgae has been carried out focusing on carotenoids, chlorophylls, lipids and fatty acids recovery, as well as the bioactivity of the extracts.
View Article and Find Full Text PDFMicroalgae as unicellular eukaryotic organisms demonstrate several advantages for biotechnological and biological applications. Natural derived microalgae products demand has increased in food, cosmetic and nutraceutical applications lately. The natural antioxidants have been used for attenuation of mitochondrial cell damage caused by oxidative stress.
View Article and Find Full Text PDFMicroalgae are well-known for their high-added value compounds and their recovery is currently of great interest. The aim of this work is the recovery of such components from through supercritical fluid extraction (SFE) with CO. The effect of the extraction temperature (40-60 °C), pressure (110-250 bar), and solvent flow rate (20-40 g/min) was tested on yield, the extract's antioxidant activity, and the phenolic, chlorophyll and carotenoid content.
View Article and Find Full Text PDFMicroalgae contain an abundance of valuable bioactive compounds such as chlorophylls, carotenoids, and phenolics and, consequently, present great commercial interest. The aim of this work is the study and optimization of recovering the aforementioned components from the microalgae species through conventional extraction in a laboratory-scale apparatus using a "green" mixture of ethanol/water 90/10 /. The effect of three operational conditions-namely, temperature (30-60 °C), duration (6-24 h) and solvent-to-biomass ratio (20-90 mL/g), was examined regarding the extracts' yield (gravimetrically), antioxidant activity, phenolic, chlorophyll, and carotenoid contents (spectrophotometric assays), as well as concentration in key carotenoids, i.
View Article and Find Full Text PDFClin Drug Investig
January 2022
Background And Objective: Hemophilia A (HA) is a rare disease that is characterized by congenital underproduction or dysfunction of the endogenous coagulation factor VIII (FVIII). The aim of the present study was to determine the value of prophylaxis versus on-demand treatment strategies for moderate to severe HA (MtSHA) patients and the value of emicizumab in the prophylaxis of MtSHA in Greece, compared with short half-life (SHL) FVIII and extended half-life (EHL) FVIII through multicriteria decision analysis (MCDA).
Methods: A literature review was performed to identify a set of criteria relevant to the therapeutic approaches and therapies under investigation.